GSK PLC (GSK)
Clinical trial NCT06693895 updates: 1. primary completion date: 2026-07-01 → 2026-11-23 2. enrollment: not set → 750 participants
Clinical trial NCT06693895 updates: 1. primary completion date: 2026-07-01 → 2026-11-23 2. enrollment: not set → 750 participants
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical